Mercedes-Benz and Stellantis have backed the solid-state battery developer, having disclosed strategic agreements a month ago.

Bukwang Pharmaceutical and Novartis Venture Fund were among the latest investors in the developer of T-cell therapies for liquid and solid cancers.

SoftBank Vision Fund 2 helped revenue growth technology provider 6sense close a $200m series E round at a $5.2bn valuation, cash used to acquire Gree-backed sales software developer Saleswhale.

Advancing foundational research from UCLA and Migal – Galilee Research Institute, ImmPact is working on T-cell therapies for liquid and solid cancers.

Mental health app developer Lyra Health raised $235m from investors including Salesforce while blockchain development software provider Secret Network launched a $225m ecosystem fund.

Vision Fund 2 invested in e-commerce software provider Shoplazza and digital therapeutics developer Big Health as part of what is becoming a busy January.

Salesforce was among the investors that backed the virtual health service’s latest round, helping it take its funding to $216m altogether.

UCL spinout Ori Biotech has raised more than $100m in a series B round led by Novalis LifeSciences, just over a year after closing a $30m series A round.

Volkswagen Group invested a nine-figure amount in 24M Technologies while SoftBank participated in a $100m series C round for Pixis.

Gemini and Smile Group were both part of the metaverse and NFT-fuelled game publisher's latest round, valuing it at $5.4bn pre-money as it makes big strides in venture capital investing.